0001362118-23-000048.txt : 20230713
0001362118-23-000048.hdr.sgml : 20230713
20230713151140
ACCESSION NUMBER: 0001362118-23-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230712
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alvarez Nicholas P
CENTRAL INDEX KEY: 0001802844
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 231086620
MAIL ADDRESS:
STREET 1: C/O LIFEMD, INC.
STREET 2: 236 FIFTH AVENUE, SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-07-12
0
0000948320
LifeMD, Inc.
LFMD
0001802844
Alvarez Nicholas P
C/O LIFEMD, INC.
236 FIFTH AVENUE, SUITE 400
NEW YORK
NY
10001
0
1
0
0
Chief Acquisition Officer
0
Common Stock
2023-07-12
4
A
0
150000
A
330000
D
Employee Stock Option (Right to Buy)
7.92
2023-07-12
4
D
0
200000
D
Common Stock
200000
0
D
The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020.
/s/ Nicholas P. Alvarez
2023-07-13